Stem cells: A new paradigm in medical therapeutics

Journal of Long-Term Effects of Medical Implants

Volumn 20, Issue 3, 2010, Pages 219-250

  Mankikar, Sadanand D ^a  

^a NONE   (Canada)

Author keywords

Cell expansion; Regenerative medicine; Sources; Therapeutic application; Tissue engineering

Indexed keywords

CELLS; CYTOLOGY; DISEASE CONTROL; DISEASES; ELEMENTARY PARTICLE SOURCES; HISTOLOGY; NEURODEGENERATIVE DISEASES; STEM CELLS; TISSUE; TISSUE ENGINEERING; TISSUE REGENERATION;

ALTERNATIVE SOLUTIONS; AMYOTROPHIC LATERAL SCLEROSIS; CELL EXPANSION; NEO-VASCULARIZATION; REGENERATIVE MEDICINE; SPINAL CORD INJURIES (SCI); STEM CELL TRANSPLANTATION; THERAPEUTIC APPLICATION;

CELL ENGINEERING;

ADIPOSE TISSUE CELL; AMNIOTIC FLUID CELL; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOREACTOR; BRAIN CELL; CELL DAMAGE; CELL DIFFERENTIATION; CELL REGENERATION; CEREBRAL PALSY; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELL; FETAL STEM CELL; FIBROBLAST; HAIR FOLLICLE; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; JUVENILE DIABETES MELLITUS; LIMBAL STEM CELL TRANSPLANTATION; LIVER CELL; MULTIPOTENT STEM CELL; NEOVASCULARIZATION (PATHOLOGY); NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; REGENERATIVE MEDICINE; SKIN CELL; SPERMATOGONIUM; SPINAL CORD INJURY; STEM CELL; STEM CELL EXPANSION; STEM CELL TRANSPLANTATION; STROKE; TISSUE ENGINEERING; TOOTH; CULTURE TECHNIQUE; REVIEW;

BIOREACTORS; CELL CULTURE TECHNIQUES; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 79958741485     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v20.i3.50     Document Type: Article

References (201)

1. Theise ND. Gastrointestinal stem cells. III. Emergent themes of liver stem cell biology: niche, quiescence, self-renewal, and plasticity. Am J Physiol Gastrointest Liver Physiol. 2006;290:G189-93.
2. Naveiras O, Daley GQ. Stem cells and their niche: a matter of fate. Cell Mol Life Sci. 2006;63:760-6.
3. Benayahu D, Akavia UD, Shur I. Differentiation of bone marrow stroma-derived mesenchymal cells. Curr Med Chem. 2007;14:173-9.
4. Snykers S, De Kock J, Rogiers V, Vanhaecke T. In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells. 2009 Mar;27(3): 577-605.
5. Tárnok A, Ulrich H, Bocsi J. Phenotypes of stem cells from diverse origin. Cytometry A. 2010 Jan;77(1):6-10.
6. Tsonis PA. Bridging knowledge gaps on the long road to regeneration: Classical models meet stem cell manipulation and bioengineering. Mol Int. 2007:7(5):249-50.
7. Saxena AK, Singh D, Gupta J. Role of stem cell research in therapeutic purpose--a hope for new horizon in medical biotechnology. J Exp Ther Oncol. 2010;8(3):223-33.
8. Mazhari R, Hare JM. Advances in cell-based therapy for structural heart disease. Prog Cardiovasc Dis. 2007 May-Jun;49(6):387-95.
9. Tesche LJ, Gerber DA. Tissue-derived stem and progenitor cells. Stem Cells Int. 2010;2010:824-76.
10. Pelacho B, Prosper F. Stem cells and cardiac disease: where are we going? Curr Stem Cell Res Ther. 2008 Dec;3(4):265-76.
11. Pal R. Embryonic stem (ES) cell-derived cardiomyocytes: a good candidate for cell therapy applications. Cell Biol Int. 2009 Mar;33(3):325-36.
12. Kane NM, Xiao Q, Baker AH, Luo Z, Xu Q, Emanueli C. Pluripotent stem cell differentiation into vascular cells: A novel technology with promises for vascular regeneration). Pharmacol Ther. 2011 Jan;129(1):29-49.
13. Kränkel N, Spinetti G, Amadesi S, Madeddu P. Targeting stem cell niches and trafficking for cardiovascular therapy. Pharmacol Ther. 2011 Jan;129(1):62-81.
14. Watt SM, Contreras M. Stem cell medicine: umbilical cord blood and its stem cell potential. Semin Fetal Neonatal Med. 2005 Jun;10(3):209-20.
15. Eve DJ, Fillmore RW, Borlongan CV, Sanberg PR. Stem cell research in "cell transplantation:" sources, geopolitical influence and transplant types. Cell Transplant. 2010;19(11):1493-509.
16. Gaspard N, Vanderhaeghen P. From stem cells to neural networks: recent advances and perspectives for neurodevelopmental disorders. Dev Med Child Neurol. 2011 Jan;53(1):13-7.
17. Pucéat M. Protocols for cardiac differentiation of embryonic stem cells. Methods. 2008 Jun;45(2):168-71.
18. Sarkar P, Rao BM. Molecular aspects of cardiac differentiation in embryonic stem cells. Crit Rev Biomed Eng. 2009;37(4-5):283-320.
19. Steel D, Hyllner J, Sartipy P. Cardiomyocytes derived from human embryonic stem cells-characteristics and utility for drug discovery. Curr Opin Drug Discov Devel. 2009 Jan;12(1):133-40.
20. Blin G, Neri T, Stefanovic S, Pucéat M. Human embryonic and induced pluripotent stem cells in basic and clinical research in cardiology. Curr Stem Cell Res Ther. 2010 Sep;5(3):215-26.
21. Narwani K, Biancotti JC, Golan-Lev T, Buehler N, Hill D, Shifman S, Benvenisty N, Lavon N. Human embryonic stem cells from aneuploid blastocysts identified by preimplantation genetic screening. In Vitro Cell Dev Biol Anim. 2010 Apr;46(3-4):309-16.
22. Olivier EN, Bouhassira EE. Differentiation of human embryonic stem cells into mesenchymal stem cells by the "raclure" method. Methods Mol Biol. 2011;690:183-93.
23. Jo CH, Kim OS, Park EY, Kim BJ, Lee JH, Kang SB, Lee JH, Han HS, Rhee SH, Yoon KS. Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Cell Tissue Res. 2008 Dec;334(3):423-33.
24. Antonucci I, Stuppia L, Kaneko Y, Yu S, Tajiri N, Bae EC, Chheda SH, Weinbren NL, Borlongan CV. Amniotic fluid as rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplant. 2010 Nov 5. [Epub ahead of print]. PMID: 21054947
25. Cohena Y, Nagler A. Hematopoietic stem-cell transplantation using umbilical-cord blood. Leuk Lymphoma. 2003 Aug;44(8):1287-99.
26. Kögler G, Somville T, Göbel U, Hakenberg P, Knipper A, Fischer J, Adams O, Krempe C, McKenzie C, Rüttgers H, Meier W, Bellmann O, Streng H, Ring A, Rosseck U, Rocha V, Wernet P. Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany. Klin Padiatr. 1999 Jul-Aug;211(4):224-32.
27. Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population. Klin Padiatr. 2004 Nov-Dec;216(6):356-63.
28. Rocha V, Wagner JE Jr., Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000;342(25):1846-54.
29. Pazdur R, Coia LR, Hoskins WJ, Wagman LD. Cancer management: a multidisciplinary approach. 2nd ed. Huntington, NY: PRR Inc.; 1998.
30. Behzad-Behbahani A, Pouransari R, Tabei SZ, Rahiminejad MS, Robati M, Yaghobi R, Nourani H, Ramzi MM, Farhadi-Andarabi A, Mojiri A, Rahsaz M, Banihashemi M, Zare N. Risk of viral transmission via bone marrow progenitor cells versus umbilical cord blood hematopoietic stem cells in bone marrow transplantation. Transplant Proc. 2005;37(7):3211-2.
31. Arien-Zakay H, Lecht S, Nagler A, Lazarovici P. Human umbilical cord blood stem cells: rational for use as a neuroprotectant in ischemic brain disease. Int J Mol Sci. 2010 Sep 21;11(9):3513-28.
32. Lauber S, Latta M, Klüter H, Müller-Steinhardt M. The Mannheim Cord Blood Bank: Experiences and perspectives for the future. Transfus Med Hemother. 2010 Apr;37(2):90-7.
33. Jacobs VR, Schneider KT. [Increasing clinical applications of stem cells from umbilical cord blood and consequences for the handling of this biomaterial] Z Geburtshilfe Neonatol. 2009 Apr;213(2):49-55.
34. Bahk JY, Jung JH, Han H, Min SK, Lee YS. Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: preliminary report of 7 cases. Exp Clin Transplant. 2010 Jun; 8(2):150-60.
35. Lee LK, Ueno M, Van Handel B, Mikkola HK. Placenta as a newly identified source of hematopoietic stem cells. Curr Opin Hematol. 2010 Jul;17(4):313-8.
36. Cai J, Li W, Su H, Qin D, Yang J, Zhu F, Xu J, He W, Guo X, Labuda K, Peterbauer A, Wolbank S, Zhong M, Li Z, Wu W, So KF, Redl H, Zeng L, Esteban MA, Pei D. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem. 2010 Apr 9;285(15):11227-34.
37. Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T, Doody M, Venter D, Pain S, Gilshenan K, Atkinson K. Comparison of human placenta-and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev. 2008 Dec;17(6):1095-107.
38. Semenov OV, Koestenbauer S, Riegel M, Zech N, Zimmermann R, Zisch AH, Malek A. Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation. Am J Obstet Gynecol. 2010 Feb;202(2):193. e1-193. e13.
39. Macias MI, Grande J, Moreno A, Domínguez I, Bornstein R, Flores AI. Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. Am J Obstet Gynecol. 2010 Nov;203(5):495. e9-495. e23.
40. Armson BA; Maternal/Fetal Medicine Committee, Society of Obstetricians and Gynaecologists of Canada. Umbilical cord blood banking: implications for perinatal care providers. J Obstet Gynaecol Can. 2005 Mar:27(3): 263-90.
41. Sun J, Allison J, McLaughlin C, Sledge L, Waters-Pick B, Wease S, Kurtzberg J. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion. 2010 Sept:50(9):1980-7.
42. American Academy of Pediatrics. Cord blood banking for future potential transplantation. Pediatrics. 2007:119(1):165-70.
43. Committee on Obstetric Practice; Committee on Genetics. ACOG committee opinion number 399, February 2008: umbilical cord blood banking. Obstet Gynecol. 2008 Feb;111(2 Pt 1):475-7.
44. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am. 1998 Jul;80(7):985-96.
45. Li M, Yu J, Li Y, Li D, Yan D, Ruan Q. CXCR4+ progenitors derived from bone mesenchymal stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Cell Reprogram. 2010 Aug;12(4):405-15.
46. Nakahara H, Misawa H, Hayashi T, Kondo E, Yuasa T, Kubota Y, Seita M, Kawamoto H, Hassan WA, Hassan RA, Javed SM, Tanaka M, Endo H, Noguchi H, Matsumoto S, Takata K, Tashiro Y, Nakaji S, Ozaki T, Kobayashi N. Bone repair by transplantation of hTERT-immortalized human mesenchymal stem cells in mice. Transplantation. 2009 Aug 15;88(3):346-53.
47. Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res. 2009 Oct;12(5):359-66.
48. Khosla S, Westendorf JJ, Mödder UI. Insights from normal bone remodeling and stem cell-based therapies for bone repair. Stem Cells. 2010;28(12):2124-28.
49. Charwat S, Gyöngyösi M, Lang I, Graf S, Beran G, Hemetsberger R, Nyolczas N, Sochor H, Glogar D. Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art. Exp Hematol. 2008 Jun;36(6):672-80.
50. Kollet O, Dar A, Lapidot T. The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization. Annu Rev Immunol. 2007;25:51-69.
51. Wu Y, Zhao RC, Tredget EE. Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells. 2010 May;28(5):905-15.
52. Astori G, Soncin S, Lo Cicero V, Siclari F, Sürder D, Turchetto L, Soldati G, Moccetti T. Bone marrow derived stem cells in regenerative medicine as advanced therapy medicinal products. Am J Transl Res. 2010 May 15;2(3):285-95.
53. Kuchment A. Scientist grows jaw bone from adult stem cells. The Record. March 2010. http://news.columbia.edu/ record/1729.
54. Bellayr IH, Gharaibeh B, Huard J, Li Y. Skeletal musclederived stem cells differentiate into hepatocyte-like cells and aid in liver regeneration. Int J Clin Exp Pathol. 2010 Mar 25;3(7):681-90.
55. Gaudio E, Carpino G, Cardinale V, Franchitto A, Onori P, Alvaro D. New insights into liver stem cells. Dig Liver Dis. 2009 Jul;41(7):455-62.
56. Oliva J, French BA, Qing X, French SW. The identification of stem cells in human liver diseases and hepatocellular carcinoma. Exp Mol Pathol. 2010 Jun;88(3):331-40.
57. Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, Shetty K, Johnson L, Reddy EP. Liver stem cells and hepatocellular carcinoma. Hepatology. 2009 Jan;49(1): 318-29.
58. Carloni G, Ponzetto A, Marchese R, Brunetti E, Crema A. Liver stem cells and possible clinical applications. Curr Stem Cell Res Ther. 2010 Dec 1;5(4):314-25.
59. Rashid ST, Corbineau S, Hannan N, Marciniak SJ, Miranda E, Alexander G, Huang-Doran I, Griffin J, Ahrlund-Richter L, Skepper J, Semple R, Weber A, Lomas DA, Vallier L. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest. 2010 Sep 1;120(9):3127-36.
60. Roelandt P, Pauwelyn KA, Sancho-Bru P, Subramanian K, Ordovas L, Vanuytsel K, Geraerts M, Firpo M, De Vos R, Fevery J, Nevens F, Hu WS, Verfaillie CM. Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells. PLoS One. 2010 Aug 11;5(8):e12101.
61. Gennero L, Roos MA, Sperber K, Denysenko T, Bernabei P, Calisti GF, Papotti M, Cappia S, Pagni R, Aimo G, Mengozzi G, Cavallo G, Reguzzi S, Pescarmona GP, Ponzetto A. Pluripotent plasticity of stem cells and liver repopulation. Cell Biochem Funct. 2010 Apr;28(3):178-89.
62. Arora V, Arora P, Munshi AK. Banking stem cells from human exfoliated deciduous teeth (SHED): saving for the future. J Clin Pediatr Dent. 2009 Summer;33(4):289-94.
63. Yan M, Yu Y, Zhang G, Tang C, Yu J. A journey from dental pulp stem cells to a bio-tooth. Stem Cell Rev. 2011;7(1):161-71.
64. Huang AH, Chen YK, Chan AW, Shieh TY, Lin LM. Isolation and characterization of human dental pulp stem/stromal cells from nonextracted crown-fractured teeth requiring root canal therapy. J Endod. 2009 May;35(5):673-81.
65. Kim SH, Kim KH, Seo BM, Koo KT, Kim TI, Seol YJ, Ku Y, Rhyu IC, Chung CP, Lee YM. Alveolar bone regeneration by transplantation of periodontal ligament stem cells and bone marrow stem cells in a canine periimplant defect model: a pilot study. J Periodontol. 2009 Nov;80(11):1815-23.
66. Feng F, Akiyama K, Liu Y, Yamaza T, Wang TM, Chen JH, Wang BB, Huang GT, Wang S, Shi S. Utility of PDL progenitors for in vivo tissue regeneration: a report of 3 cases. Oral Dis. 2010 Jan;16(1):20-8.
67. Yang ZH, Zhang XJ, Dang NN, Ma ZF, Xu L, Wu JJ, Sun YJ, Duan YZ, Lin Z, Jin Y. Apical tooth germ cell-conditioned medium enhances the differentiation of periodontal ligament stem cells into cementum/periodontal ligament-like tissues. J Periodontal Res. 2009 Apr;44(2): 199-210.
68. Yang Z, Jin F, Zhang X, Ma D, Han C, Huo N, Wang Y, Zhang Y, Lin Z, Jin Y. Tissue engineering of cementum/ periodontal-ligament complex using a novel threedimensional pellet cultivation system for human periodontal ligament stem cells. Tissue Eng Part C Methods. 2009 Dec;15(4):571-81.
69. Marei MK, Saad MM, El-Ashwah AM, Ei-Backly RM, Al-Khodary MA. Experimental formation of periodontal structure around titanium implants utilizing bone marrow mesenchymal stem cells: a pilot study. J Oral Implantol. 2009;35(3):106-29.
70. Carrier P, Deschambeault A, Audet C, Talbot M, Gauvin R, Giasson CJ, Auger FA, Guérin SL, Germain L. Impact of cell source on human cornea reconstructed by tissue engineering. Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2645-52.
71. Szabo E, Rampalli S, Risueño RM, Schnerch A, Mitchell R, Fiebig-Comyn A, Levadoux-Martin M, Bhatia M. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature. 2010 Nov 25;468(7323):521-6.
72. Jotzu C, Alt E, Welte G, Li J, Hennessy BT, Devarajan E, Krishnappa S, Pinilla S, Droll L, Song YH. Adipose tissuederived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor-derived factors. Anal Cell Pathol (Amst). 2010 Jan 1;33(2):61-79.
73. Caviggioli F, Vinci V, Salval A, Klinger M. Human adiposederived stem cells: isolation, characterization and applications in surgery. ANZ J Surg. 2009 Nov;79(11):856.
74. Rada T, Reis RL, Gomes ME. Adipose tissue-derived stem cells and their application in bone and cartilage tissue engineering. Tissue Eng Part B Rev. 2009 Jun;15(2): 113-25.
75. Patel J, Gudehithlu KP, Dunea G, Arruda JA, Singh AK. Foreign body-induced granulation tissue is a source of adult stem cells. Transl Res. 2010 Apr;155(4):191-9.
76. Hunt DP, Sajic M, Phillips H, Henderson D, Compston A, Smith K, Chandran S. Origins of gliogenic stem cell populations within adult skin and bone marrow. Stem Cells Dev. 2010 Jul;19(7):1055-65.
77. Chimge NO, Bayarsaihan D. Generation of neural crest progenitors from human embryonic stem cells. J Exp Zool B Mol Dev Evol. 2010 Mar 15;314(2):95-103.
78. Delfino-Machín M, Chipperfield TR, Rodrigues FS, Kelsh RN. The proliferating field of neural crest stem cells. Dev Dyn. 2007 Dec;236(12):3242-54.
79. Jiang X, Gwye Y, McKeown SJ, Bronner-Fraser M, Lutzko C, Lawlor ER. Isolation and characterization of neural crest stem cells derived from in vitro-differentiated human embryonic stem cells. Stem Cells Dev. 2009 Sep;18(7):1059-70.
80. Lee G, Kim H, Elkabetz Y, Al Shamy G, Panagiotakos G, Barberi T, Tabar V, Studer L. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol. 2007 Dec;25(12):1468-75.
81. Darsalia V, Allison SJ, Cusulin C, Monni E, Kuzdas D, Kallur T, Lindvall O, Kokaia Z. Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cereb Blood Flow Metab. 2011;31(1):235-42.
82. Ferrari D, Binda E, De Filippis L, Vescovi AL. Isolation of neural stem cells from neural tissues using the neurosphere technique. Curr Protoc Stem Cell Biol. 2010 Nov; Chapter 2: Unit2D.6.
83. Pearce V. Stem cells and neuroprotection: understanding the players. Int J Mol Sci. 2010 Sep 15;11(9):3288-97.
84. Kanemura Y. Development of cell-processing systems for human stem cells (neural stem cells, mesenchymal stem cells, and iPS cells) for regenerative medicine. Keio J Med. 2010;59(2):35-45.
85. Yang L, Peng R. Unveiling hair follicle stem cells. Stem Cell Rev. 2010 Dec;6(4):658-64.
86. Amoh Y, Katsuoka K, Hoffman RM. The advantages of hair follicle pluripotent stem cells over embryonic stem cells and induced pluripotent stem cells for regenerative medicine. J Dermatol Sci. 2010 Dec;60(3):131-7.
87. Amoh Y, Hamada Y, Aki R, Kawahara K, Hoffman RM, Katsuoka K. Direct transplantation of uncultured hair-follicle pluripotent stem (hfPS) cells promotes the recovery of peripheral nerve injury. J Cell Biochem. 2010 May;110(1):272-7.
88. Meyer-Blazejewska EA, Call MK, Yamanaka O, Liu H, Schlötzer-Schrehardt U, Kruse FE, Kao WW. From hair to cornea: Towards the therapeutic use of hair follicle-derived stem cells in the treatment of limbal stem cell deficiency. Stem Cells. 2011 Jan;29(1):57-66.
89. Meyer-Blazejewska EA, Kruse FE, Bitterer K, Meyer C, Hofmann-Rummelt C, Wünsch PH, Schlötzer-Schrehardt U. Preservation of the limbal stem cell phenotype by appropriate culture techniques. Invest Ophthalmol Vis Sci. 2010 Feb;51(2):765-74.
90. Ebata KT, Yeh JR, Zhang X, Nagano MC. The application of biomarkers of spermatogonial stem cells for restoring male fertility. Dis Markers. 2008;24(4-5):267-76.
91. Hwang K, Lamb DJ. New advances on the expansion and storage of human spermatogonial stem cells. Curr Opin Urol. 2010 Nov;20(6):510-4.
92. McLean DJ. Spermatogonial stem cell transplantation, testicular function, and restoration of male fertility in mice. Methods Mol Biol. 2008;450:149-62.
93. Sadri-Ardekani H, Mizrak SC, van Daalen SK, Korver CM, Roepers-Gajadien HL, Koruji M, Hovingh S, de Reijke TM, de la Rosette JJ, van der Veen F, de Rooij DG, Repping S, van Pelt AM. Propagation of human spermatogonial stem cells in vitro. JAMA. 2009 Nov 18;302(19):2127-34.
94. Schlatt S, Ehmcke J, Jahnukainen K. Testicular stem cells for fertility preservation: preclinical studies on male germ cell transplantation and testicular grafting. Pediatr Blood Cancer. 2009 Aug;53(2):274-80.
95. Ho JH, Ma WH, Tseng TC, Chen YF, Chen MH, Lee OK. Isolation and characterization of multi-potent stem cells from human orbital fat tissues. Tissue Eng Part A. 2011 Jan;17(1-2):255-66.
96. Baumert B, Grymuła K, Pietruszka D, Kotowski M, Mielczarek M, Dziedziejko V, Hałasa M, Czerny B, Walczak M, Machaliński B. An optimization of hematopoietic stem and progenitor cell isolation for scientific and clinical purposes by the application of a new parameter determining the hematopoietic graft efficacy. Folia Histochem Cytobiol. 2008;46(3):299-305.
97. Rumiantsev SA, Maiorova OA, Rumiantsev AG. [Umbilical blood is a source of hemopoietic stem cells for transplantation] Ter Arkh. 2007;79(7):53-7.
98. Urosević I, Balint B, Popović S. Peripiheral blood hematopoietic stem cells--biology, apheresis collection and cryopreservation. Med Pregl. 2007 Jan-Feb;60(1-2):42-7.
99. Berz D, McCormack EM, Winer ES, Colvin GA, Quesenberry PJ. Cryopreservation of haematopoetic stem cells. Am J. Hematol. 2007:82:463-72.
100. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Gabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998:339:1565-77.
101. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, Verfaillie CM, Wagner JE. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with haematological malignancy. Blood. 2005:105:1343-7.
102. Boxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci USA 2003:100:645-50.
103. Strauss RG, Pennel BJ, Stump DC. A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion 2002:42:27-36.
104. Hayakawa J, Joyal EG, Gildner JF, Washington KN, Phang OA, Uchida N, Hsieh MM, Tisdale JF. 5% Dimethyl sulfoxide (DMSO) and pentastarch improve cryopreservation of cord blood cells over 10% DMSO. Transfusion. 2010 Oct:50(10):2158-66.
105. Zambelli A, Poggi G, Da Parda G, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Robustelli della Cuna G. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res. 1998:18:4705-8.
106. Davis JM, Rowley SD, Braine HG, Piantadosi S, Santos GW. Clinical tosicity of cryopreserved bone marrow graft infusion. Blood. 1990:75:781-6.
107. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P. Severe respiratory depression after dimethylsulfoxide-containing autologous stem cell infusion in patients with Al. amyloidosis. Bone Marrow Transplant. 2000:25:1299-301.
108. Hequet O, Dumontet C, El-Jaafari-Corbin A, Salles G, Espinouse D, Arnaud P, Thieblemont C, Bouafia F, Coiffier B. Epileptic seizures after autologous paerpheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma. Bone Marrow Transplant. 2002:29:544.
109. Burger J, Gilmore MJ, Jackson B, Prentice HG. Acute hemoglobinaemia associated with the reinfusion of bone marrow buffy coat for autologous bone marrow transplantation. Bone Marrow Transplant. 1991:7:22-4.
110. Akkok CA, Liseth K, Lokeland T, Tefre K, Bruserud O, Abrahasen JF. Autologous peripheral blood cells cryopreserved with 5 and 10 percent dimethylsulfoxide alone give comparable hematopoietic reconstitution after transplantation. Transfusion. 2008:48:877-83.
111. Liseth K, Ersvær E, Abrahamsen JF, Nesthus I, Ryningen A, Bruserud O. Long-term cryopreservation of autologous stem cell grafts: a clinical and experimental study of hematopoietic and immunocompetent cells. Transfusion. 2009 Aug;49(9):1709-19.
112. Alencar S, Garnica M, Luiz RR, Nogueira CM, Borojevic R, Maiolino A, Dutra HS. Cryopreservation of peripheral blood stem cells: the influence of cell concentration on cellular and hematopoietic recovery. Transfusion. 2010;50(11):2402-12.
113. Zhang HT, Chen H, Zhao H, Dai YW, Xu RX. Neural stem cells differentiation ability of human umbilical cord mesenchymal stromal cells is not altered by cryopreservation. Neurosci Lett. 2011 Jan 3;487(1):118-22.
114. Duong HK, Dumont C, Manocchio S, Sterle C, Zydiac L, Figueroa P. Long-term cryopreservation of autologous stem cell grafts: Stability of hematopoietic stem cells stored up to 16 years. Transfusion. 2010:50(suppl):219A.
115. Jahnukainen K, Ehmcke J, Hergenrother SD, Schlatt S. Effect of cold storage and cryopreservation of immature non-human primate testicular tissue on spermatogonial stem cell potential in xenografts. Hum Reprod. 2007 Apr;22(4):1060-7.
116. Wyns C, Curaba M, Vanabelle B, Van Langendonckt A, Donnez J. Options for fertility preservation in prepubertal boys. Hum Reprod Update. 2010 May-Jun;16(3):312-28.
117. Oktay K, Oktem O. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience. Fertil Steril. 2010 Feb;93(3):762-8.
118. Blass DP, Fu P, Delgado MA, Light CT, Coughlin D, Dang G, Kiran S, McMannis JD. Hematopoietic assay via luminescence for measuring the effects of varying storage temperatures on cord blood stem cell potency. Transfusion. 2010:50 (suppl):25A.
119. Jankowski RJ, Haluszczak C, Trucco M, Huard J. Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. Hum Gene Ther. 2001 Apr 10;12(6):619-28.
120. Shupe TD, Piscaglia AC, Oh SH, Gasbarrini A, Petersen BE. Isolation and characterization of hepatic stem cells, or "oval cells, " from rat livers. Methods Mol Biol. 2009;482:387-405.
121. Gauthaman K, Fong CY, Subramanian A, Biswas A, Bongso A. ROCK inhibitor Y-27632 increases thaw-survival rates and preserves stemness and differentiation potential of human Wharton's jelly stem cells after cryopreservation. Stem Cell Rev. 2010 Dec;6(4):665-76.
122. Buchanan SS, Pyatt DW, Carpenter JF. Preservation of differentiation and clonogenic potential of human hema topoietic stem and progenitor cells during lyophilization and ambient storage. PLoS One. 2010 Sep 1;5(9).
123. Mariappan I, Maddileti S, Savy S, Tiwari S, Gaddipati S, Fatima A, Sangwan VS, Balasubramanian D, Vemuganti GK. In vitro culture and expansion of human limbal epithelial cells. Nat Protoc. 2010 Aug;5(8):1470-9.
124. Zajicova A, Pokorna K, Lencova A, Krulova M, Svobodova E, Kubinova S, Sykova E, Pradny M, Michalek J, Svobodova J, Munzarova M, Holan V. Treatment of ocular surface injuries by limbal and mesenchymal stem cells growing on nanofiber scaffolds. Cell Transplant. 2010:19(10):1281-90.
125. Lapillonne H, Kobari L, Mazurier C, Tropel P, Giarratana MC, Zanella-Cleon I, Kiger L, Wattenhofer-Donzé M, Puccio H, Hebert N, Francina A, Andreu G, Viville S, Douay L. Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica. 2010 Oct;95(10):1651-9.
126. Matikainen T, Laine J. Placenta--an alternative source of stem cells. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):544-9.
127. Auker M, Bradbury H, Winterstein A, Daneault B, Kelley J, Briggs B, Phillips G, Devine S, O'Donnell L. The effect of fold dilution on cord blood thaw methods. Transfusion. 2010:50 (suppl):218A.
128. Assfaw T, Bez O, Kaur I, Harris AN, Arcenneux W, Shen A, Ponweera N, Ramuirez A, Shpall E, McMannis JD. Comparison of three methods of expanding cord blood stem cells. Transfusion. 2010:50(suppl):219A.
129. Kedong S, Xiubo F, Tianqing L, Macedo HM, Lili J, Meiyun F, Fangxin S, Xuehu M, Zhanfeng C. Simultaneous expansion and harvest of hematopoietic stem cells and mesenchymal stem cells derived from umbilical cord blood. J Mater Sci Mater Med. 2010 Dec;21(12):3183-93.
130. Eibes G, dos Santos F, Andrade PZ, Boura JS, Abecasis MM, da Silva CL, Cabral JM. Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system. J Biotechnol. 2010 Apr 15;146(4):194-7.
131. Doran MR, Markway BD, Clark A, Athanasas-Platsis S, Brooke G, Atkinson K, Nielsen LK, Cooper-White JJ. Membrane bioreactors enhance microenvironmental conditioning and tissue development. Tissue Eng Part C Methods. 2010 Jun;16(3):407-15.
132. Ito CY, Kirouac DC, Madlambayan GJ, Yu M, Rogers I, Zandstra PW. The AC133+CD38-, but not the rhodaminelow, phenotype tracks LTC-IC and SRC function in human cord blood ex vivo expansion cultures. Blood. 2010 Jan 14;115(2):257-60.
133. Weber C, Freimark D, Pörtner R, Pino-Grace P, Pohl S, Wallrapp C, Geigle P, Czermak P. Expansion of human mesenchymal stem cells in a fixed-bed bioreactor system based on non-porous glass carrier--part A: inoculation, cultivation, and cell harvest procedures. Int J Artif Organs. 2010 Aug;33(8):512-25.
134. Storm MP, Orchard CB, Bone HK, Chaudhuri JB, Welham MJ. Three-dimensional culture systems for the expansion of pluripotent embryonic stem cells. Biotechnol Bioeng. 2010 Nov 1;107(4):683-95.
135. Subramanian K, Park Y, Verfaillie CM, Hu WS. Scalable expansion of multipotent adult progenitor cells as threedimensional cell aggregates. Biotechnol Bioeng. 2011 Feb;108(2):364-75.
136. Alfred R, Gareau T, Krawetz R, Rancourt D, Kallos MS. Serum-free scaled up expansion and differentiation of murine embryonic stem cells to osteoblasts in suspension bioreactors. Biotechnol Bioeng. 2010 Aug 1;106(5):829-40.
137. Lock LT, Tzanakakis ES. Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng Part A. 2009 Aug;15(8):2051-63.
138. Madlambayan GJ, Rogers I, Purpura KA, Ito C, Yu M, Kirouac D, Casper RF, Zandstra PW. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess. Biol Blood Marrow Transplant. 2006 Oct;12(10):1020-30.
139. Serra M, Brito C, Sousa MF, Jensen J, Tostões R, Clemente J, Strehl R, Hyllner J, Carrondo MJ, Alves PM. Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J Biotechnol. 2010 Aug 2;148(4):208-15.
140. Olmer R, Haase A, Merkert S, Cui W, Palecek J, Ran C, Kirschning A, Scheper T, Glage S, Miller K, Curnow EC, Hayes ES, Martin U. Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res. 2010 Jul;5(1):51-64.
141. Serra M, Brito C, Costa EM, Sousa MF, Alves PM. Integrating human stem cell expansion and neuronal differentiation in bioreactors. BMC Biotechnol. 2009 Sep 22;9:82.
142. Krawetz R, Taiani JT, Liu S, Meng G, Li X, Kallos MS, Rancourt DE. Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng Part C Methods. 2010 Aug;16(4):573-82.
143. Smith J, Merrick D. Embryonic skeletal muscle microexplant culture and isolation of skeletal muscle stem cells. Methods Mol Biol. 2010;633:29-56.
144. Rodríguez-Pizà I, Richaud-Patin Y, Vassena R, González F, Barrero MJ, Veiga A, Raya A, Belmonte JC. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions. Stem Cells. 2010 Jan;28(1):36-44.
145. Labbé B, Marceau-Fortier G, Fradette J. Cell sheet technology for tissue engineering: the self-assembly approach using adipose-derived stromal cells. Methods Mol Biol. 2011;702:429-441.
146. Rotter N, Schwarz S, Jakob M, Brandau S, Wollenberg B, Lang S. [Salivary gland stem cells:Can they restore radiation-induced salivary gland dysfunction?] HNO. 2010 Jun;58(6):556-63.
147. Supronowicz P, Gill E, Trujillo A, Thula T, Zhukauskas R, Ramos T, Cobb R. Human adipose-derived side population stem cells cultured on demineralized bone matrix for bone tissue engineering. Tissue Eng Part A. 2011 March;17(5-6):789-98.
148. Tsigkou O, Pomerantseva I, Spencer JA, Redondo PA, Hart AR, O'Doherty E, Lin Y, Friedrich CC, Daheron L, Lin CP, Sundback CA, Vacanti JP, Neville C. Engineered vascularized bone grafts. Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3311-6.
149. Fröhlich M, Grayson WL, Wan LQ, Marolt D, Drobnic M, Vunjak-Novakovic G. Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther. 2008 Dec;3(4):254-64.
150. Tortelli F, Tasso R, Loiacono F, Cancedda R. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials. 2010 Jan;31(2): 242-9.
151. Liu GP, Li YL, Sun J, Cui L, Zhang WJ, Cao YL. [Repair of calvarial defects with human umbilical cord blood derived mesenchymal stem cells and demineralized bone matrix in athymic rats] Zhonghua Zheng Xing Wai Ke Za Zhi. 2010 Jan;26(1):34-8.
152. Zhao Y, Zhang S, Zhou J, Wang J, Zhen M, Liu Y, Chen J, Qi Z. The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cells. Biomaterials. 2010 Jan;31(2):296-307.
153. Nirmalanandhan VS, Rao M, Shearn JT, Juncosa-Melvin N, Gooch C, Butler DL. Effect of scaffold material, construct length and mechanical stimulation on the in vitro stiffness of the engineered tendon construct. J Biomech. 2008;41(4):822-8.
154. Lin N, Lin J, Bo L, Weidong P, Chen S, Xu R. Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells in an alginate scaffold. Cell Prolif. 2010 Oct;43(5):427-34.
155. Schmidt D, Dijkman PE, Driessen-Mol A, Stenger R, Mariani C, Puolakka A, Rissanen M, Deichmann T, Odermatt B, Weber B, Emmert MY, Zund G, Baaijens FP, Hoerstrup SP. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol. 2010 Aug 3;56(6):510-20.
156. Sodian R, Schaefermeier P, Abegg-Zips S, Kuebler WM, Shakibaei M, Daebritz S, Ziegelmueller J, Schmitz C, Reichart B. Use of human umbilical cord blood-derived progenitor cells for tissue-engineered heart valves. Ann Thorac Surg. 2010 Mar;89(3):819-28.
157. Ramaswamy S, Gottlieb D, Engelmayr GC Jr, Aikawa E, Schmidt DE, Gaitan-Leon DM, Sales VL, Mayer JE Jr, Sacks MS. The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells. Biomaterials. 2010 Feb;31(6):1114-25.
158. Schleicher M, Wendel HP, Fritze O, Stock UA. In vivo tissue engineering of heart valves: evolution of a novel concept. Regen Med. 2009 Jul;4(4):613-9.
159. Ugurlucan M, Yerebakan C, Furlani D, Ma N, Steinhoff G. Cell sources for cardiovascular tissue regeneration and engineering. Thorac Cardiovasc Surg. 2009 Mar;57(2):63-73.
160. Siepe M, Akhyari P, Lichtenberg A, Schlensak C, Beyersdorf F. Stem cells used for cardiovascular tissue engineering. Eur J Cardiothorac Surg. 2008 Aug;34(2):242-7.
161. Laschke MW, Vollmar B, Menger MD. Inosculation: connecting the life-sustaining pipelines Tissue Eng Part B Rev. 2009 Dec;15(4):455-65.
162. Laschke MW, Mussawy H, Schuler S, Kazakov A, Rücker M, Eglin D, Alini M, Menger MD. Short-term cultivation of in situ prevascularized tissue constructs accelerates inosculation of their preformed microvascular networks after implantation into the host tissue. Tissue Eng Part A. 2011 March;17(5-6):841:53.
163. Martinez EC, Kofidis T. Adult stem cells for cardiac tissue engineering. J Mol Cell Cardiol. 2011 Feb;50(2):312-9.
164. Hall MN, Rosenkrantz WS, Hong JH, Griffin CE, Mendelsohn CM. Evaluation of the potential use of adiposederived mesenchymal stromal cells in the treatment of canine atopic dermatitis: a pilot study. Vet Ther. 2010 Summer;11(2):E1-E14.
165. Mizuno H, Nambu M. Adipose-derived stem cells for skin regeneration. Methods Mol Biol. 2011;702:453-9.
166. Madonna R, De Caterina R. Adipose tissue: a new source for cardiovascular repair. J Cardiovasc Med (Hagerstown). 2010 Feb;11(2):71-80.
167. Ding G, Wang W, Liu Y, Zhang C, Wang S. Mesenchymal stem cell transplantation: A potential therapy for oral lichen planus. Med Hypotheses. 2011 March;76:322-4.
168. Boeuf S, Richter W. Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors. Stem Cell Res Ther. 2010 Oct 13;1(4):31.
169. Samuel GN, Kerridge IH, O'Brien TA. Umbilical cord blood banking: public good or private benefit? Med J Aust. 2008 May 5;188(9):533-5.
170. Trotman J, Presgrave P, Kwan Y, Tiley C, Estell J, Watson AM, O'Brien TA, Peters D. Consensus guidelines for 'rainy day' autologous stem cell harvests in New South Wales. Intern Med J. 2008 Apr;38(4):229-34.
171. Mizuno H. Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J Nippon Med Sch. 2009 Apr;76(2):56-66.
172. Nie C, Yang D, Xu J, Si Z, Jin X, Zhang J. Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant. 2010 Aug 18. PMID: 20719083.
173. Merritt EK, Hammers DW, Tierney M, Suggs LJ, Walters TJ, Farrar RP. Functional assessment of skeletal muscle regeneration utilizing homologous extracellular matrix as scaffolding. Tissue Eng Part A. 2010 Apr;16(4): 1395-405.
174. Merritt EK, Cannon MV, Hammers DW, Le LN, Gokhale R, Sarathy A, Song TJ, Tierney MT, Suggs LJ, Walters TJ, Farrar RP. Repair of traumatic skeletal muscle injury with bone-marrow-derived mesenchymal stem cells seeded on extracellular matrix. Tissue Eng Part A. 2010 Sep;16(9):2871-81.
175. Ravens U. [Electrophysiological properties of stem cells] [Article in German] Herz. 2006 Apr;31(2):123-6.
176. Hejcl A, Sedý J, Kapcalová M, Toro DA, Amemori T, Lesný P, Likavcanová-Mašínová K, Krumbholcová E, Prádný M, Michálek J, Burian M, Hájek M, Jendelová P, Syková E. Hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury. Stem Cells Dev. 2010 Oct;19(10):1535-46.
177. Goldschlager T, Ghosh P, Zannettino A, Gronthos S, Rosenfeld JV, Itescu S, Jenkin G. Cervical motion preservation using mesenchymal progenitor cells and pentosan polysulfate, a novel chondrogenic agent: preliminary study in an ovine model. Neurosurg Focus. 2010 Jun;28(6):E4.
178. Joe AW, Gregory-Evans K. Mesenchymal stem cells and potential applications in treating ocular disease. Curr Eye Res. 2010 Nov;35(11):941-52.
179. Gondi CS, Gogineni VR, Chetty C, Dasari VR, Gorantla B, Gujrati M, Dinh DH, Rao JS. Induction of apoptosis in glioma cells requires cell-to-cell contact with human umbilical cord blood stem cells. Int J Oncol. 2010 May;36(5):1165-73.
180. Wong L, Bushman W. Comment on basal epithelial stem cells as efficient targets for prostate cancer initiation. Stem Cell Res Ther. 2010 Jun 8;1(2):16.
181. Miri A, Al-Deiri B, Dua HS. Long-term outcomes of autolimbal and allolimbal transplants. Ophthalmology. 2010 Jun;117(6):1207-13.
182. Rama P, Matuska S, Paganoni G, Spinelli A, De Luca M, Pellegrini G. Limbal stem-cell therapy and long-term corneal regeneration. N Engl J Med. 2010 Jul 8;363(2): 147-55.
183. Burman S, Sangwan V. Cultivated limbal stem cell transplantation for ocular surface reconstruction. Clin Ophthalmol. 2008 Sep;2(3):489-502.
184. Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity utilizing diverse cellular mechanisms. J Virol. 2011 Jan;85(1):43-50.
185. Brandow CC, Richman C, Tuscano J, Taylor D, Ratliff B, Cox T, Fernando LP. Analyzing the effects of ABO mismatch on stem cell engraftment. Transfusion. 2010:50 (suppl):220A.
186. Cohn CS, Gaensler KL, Nambiar A. Engraftment associated complications: is it an allo or an autoantibody? Transfusion. 2010:50(suppl):223A.
187. Revoltella RP, Papini S, Rosellini A, Michelini M, Franceschini V, Ciorba A, Bertolaso L, Magosso S, Hatzopoulos S, Lorito G, Giordano P, Simoni E, Ognio E, Cilli M, Saccardi R, Urbani S, Jeffery R, Poulsom R, Martini A. Cochlear repair by transplantation of human cord blood CD133+ cells to nod-scid mice made deaf with kanamycin and noise. Cell Transplant. 2008;17(6):665-78.
188. Henning RJ. Stem cells in cardiac repair. Future Cardiol. 2011 Jan;7(1):99-117.
189. Chua SJ, Bielecki R, Yamanaka N, Fehlings MG, Rogers IM, Casper RF. The effect of umbilical cord blood cells on outcomes after experimental traumatic spinal cord injury. Spine (Phila Pa 1976). 2010 Jul 15;35(16):1520-6.
190. Mehta T, Feroz A, Thakkar U, Vanikar A, Shah V, Trivedi H. Subarachnoid placement of stem cells in neurological disorders. Transplant Proc. 2008 May;40(4):1145-7.
191. Harris DT. Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev. 2008 Dec;4(4):269-74.
192. Herranz AS, Gonzalo-Gobernado R, Reimers D, Asensio MJ, Rodríguez-Serrano M, Bazán E. Applications of human umbilical cord blood cells in central nervous system regeneration. Curr Stem Cell Res Ther. 2010 Mar;5(1): 17-22.
193. Haller MJ, Wasserfall CH, McGrail KM, Cintron M, Brusko TM, Wingard JR, Kelly SS, Shuster JJ, Atkinson MA, Schatz DA. Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care. 2009 Nov;32(11):2041-6.
194. Haller MJ, Viener HL, Brusko T, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol. 2008 Jun;36(6):710-5.
195. Fang NT, Xie SZ, Wang SM, Gao HY, Wu CG, Pan LF. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Chin Med J (Engl). 2007 Apr 20;120(8):696-702.
196. Volponi AA, Pang Y, Sharpe PT. Stem cell-based biological tooth repair and regeneration. Trends Cell Biol. 2010 Dec;20(12):715-22.
197. Galán L, Guerrero-Sola A, Gómez-Pinedo U, Matias-Guiu J. Cell therapy in amyotrophic lateral sclerosis: science and controversy. Neurologia. 2010 Oct;25(8):467-9.
198. Harris DT. Non-haematological uses of cord blood stem cells. Br J Haematol. 2009 Oct;147(2):177-84.
199. Egashira T, Fukuda K. [The possibility of regenerative medicine for myocardial infarction and ischemic cardiomyopathy by using several stem cells.] Nippon Rinsho. 2010 Apr;68(4):731-6.
200. Ilic D. Industry Update: Latest developments in stem cell research and regenerative medicine. Regen Med. 2010 Nov;5(6):847-51.
201. Yuasa S, Fukuda K. Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era. Expert Rev Cardiovasc Ther. 2008 Jul;6(6):803-10.